About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
targeted mutation 3, Klaus Rajewsky
MGI:3778920
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CD2-icre)4Kio/0
involves: C57BL/6 * C57BL/10 * CBA/Ca MGI:3783574
cn2
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0
involves: C57BL/6 * C57BL/10 * CBA/Ca MGI:3783575


Genotype
MGI:3783574
cn1
Allelic
Composition
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sor+
Tg(CD2-icre)4Kio/0
Genetic
Background
involves: C57BL/6 * C57BL/10 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky mutation (1 available); any Gt(ROSA)26Sor mutation (996 available)
Tg(CD2-icre)4Kio mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• mice exhibit more CD19+B220loCD5+CD43+CD23- B-1a cells in the spleen and peritoneal cavity compared to in wild-type mice

hematopoietic system
• mice exhibit more CD19+B220loCD5+CD43+CD23- B-1a cells in the spleen and peritoneal cavity compared to in wild-type mice




Genotype
MGI:3783575
cn2
Allelic
Composition
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0
Genetic
Background
involves: C57BL/6 * C57BL/10 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky mutation (1 available); any Gt(ROSA)26Sor mutation (996 available)
Tg(CD2-icre)4Kio mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all mice die by 55 weeks of age

immune system
N
• despite increased immunoglobulin, cytokine levels in the blood are normal
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• prior to 14 weeks of age, mice exhibit a 2-fold higher percentage of thymocytes at the double negative stage compared to in wild-type mice
• however, the total number of thymocytes is unchanged
• at 5 weeks of age
• in the spleen and peripheral lymph nodes
• mice exhibit more CD19+B220loCD5+CD43+CD23- B-1a cells in the spleen and peritoneal cavity compared to in wild-type mice
• spleen and lymph node B cells exhibit increased cell size compared to in wild-type mice
• CD4+ T cells exhibit increased proliferation and survival following stimulation with CD3 alone unlike wild-type cells
• the spleen marginal zone is disrupted unlike in wild-type mice
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• mice exhibit massive infiltration of lymphocytes into the salivary glands and lungs with some infiltration of the kidneys unlike in wild-type mice
• B cells are more resistance than in wild-type mice to Fas-mediated cell death following activation
• activated B cells exhibit enhanced proliferation and survival compared to wild-type cells
• B-2 cell proliferation is enhanced following activation with anti-IgM or lipopolysaccharides unlike in wild-type cells
• 4- to 6-fold at 8 to 12 weeks of age
• 4- to 6-fold at 8 to 12 weeks of age
• 4- to 6-fold at 8 to 12 weeks of age
• 4- to 6-fold at 8 to 12 weeks of age
• more CD4+ T cells produce IFN-gamma and IL-10 but not IL-4 or TNF than wild-type cells
• CD4+T cells from older mice produce more IFN-gamma and IL-10 than CD4+ T cells from younger mice
• activated T cells exhibit enhanced proliferation and survival compared to wild-type cells

renal/urinary system
• a subset of mice show marked accumulation of IgG and the C3d component of complement in the mesangium and segmentally in the periphery of glomeruli
• mice exhibit mesangial expansion unlike in wild-type mice
• mice exhibit enlarged renal glomeruli with hypercellularity and mesangial expansion unlike in wild-type mice
• in some mice

homeostasis/metabolism

hematopoietic system
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• prior to 14 weeks of age, mice exhibit a 2-fold higher percentage of thymocytes at the double negative stage compared to in wild-type mice
• however, the total number of thymocytes is unchanged
• at 5 weeks of age
• in the spleen and peripheral lymph nodes
• mice exhibit more CD19+B220loCD5+CD43+CD23- B-1a cells in the spleen and peritoneal cavity compared to in wild-type mice
• spleen and lymph node B cells exhibit increased cell size compared to in wild-type mice
• CD4+ T cells exhibit increased proliferation and survival following stimulation with CD3 alone unlike wild-type cells
• the spleen marginal zone is disrupted unlike in wild-type mice
• B cells are more resistance than in wild-type mice to Fas-mediated cell death following activation
• activated B cells exhibit enhanced proliferation and survival compared to wild-type cells
• B-2 cell proliferation is enhanced following activation with anti-IgM or lipopolysaccharides unlike in wild-type cells
• 4- to 6-fold at 8 to 12 weeks of age
• 4- to 6-fold at 8 to 12 weeks of age
• 4- to 6-fold at 8 to 12 weeks of age
• 4- to 6-fold at 8 to 12 weeks of age
• more CD4+ T cells produce IFN-gamma and IL-10 but not IL-4 or TNF than wild-type cells
• CD4+T cells from older mice produce more IFN-gamma and IL-10 than CD4+ T cells from younger mice
• activated T cells exhibit enhanced proliferation and survival compared to wild-type cells

growth/size/body
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice
• spleens and lymph nodes are enlarged up to 30-fold in terms of weight and cell number compared to in wild-type mice

cellular
• B-2 cell proliferation is enhanced following activation with anti-IgM or lipopolysaccharides unlike in wild-type cells





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/01/2024
MGI 6.24
The Jackson Laboratory